Inspira Technologies OXY B.H.N. (IINN) Stock Price, News & Analysis

Company Overview

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Key Stats

• Today's Range: $1.40 to $1.65
• 50-Day Range: $0.43 to $1.54
• 52-Week Range: $0.40 to $1.66
• Volume: 2.30 million shs
• Average Volume: 575,782 shs
• Market Capitalization: $18.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.00
• Consensus Rating: Buy

Inspira Technologies OXY B.H.N. Stock Analysis - MarketRank™

Inspira Technologies OXY B.H.N. scored higher than 57% of companies evaluated by MarketBeat, and ranked 434th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Inspira Technologies OXY B.H.N. has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Inspira Technologies OXY B.H.N. has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Inspira Technologies OXY B.H.N. has a P/B Ratio of 4.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.75% of the float of Inspira Technologies OXY B.H.N. has been sold short.

Short Interest Ratio / Days to Cover

Inspira Technologies OXY B.H.N. has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Inspira Technologies OXY B.H.N. has recently decreased by 36.32%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inspira Technologies OXY B.H.N. does not currently pay a dividend.

Dividend Growth

Inspira Technologies OXY B.H.N. does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.75% of the float of Inspira Technologies OXY B.H.N. has been sold short.

Short Interest Ratio / Days to Cover

Inspira Technologies OXY B.H.N. has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Inspira Technologies OXY B.H.N. has recently decreased by 36.32%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.21

News Sentiment

Inspira Technologies OXY B.H.N. has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Inspira Technologies OXY B.H.N. this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Inspira Technologies OXY B.H.N. insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.40% of the stock of Inspira Technologies OXY B.H.N. is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 12.72% of the stock of Inspira Technologies OXY B.H.N. is held by institutions.

IINN Stock Analysis - Frequently Asked Questions

How have IINN shares performed this year?

Inspira Technologies OXY B.H.N.'s stock was trading at $1.02 at the start of the year. Since then, IINN stock has increased by 40.3% and is now trading at $1.4310.

When did Inspira Technologies OXY B.H.N. IPO?

Inspira Technologies OXY B.H.N. (IINN) raised $19 million in an IPO on Wednesday, July 14th 2021. The company issued 2,909,091 shares at $5.50-$7.50 per share.

How do I buy shares of Inspira Technologies OXY B.H.N.?

Shares of IINN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Inspira Technologies OXY B.H.N. own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspira Technologies OXY B.H.N. investors own include Plug Power (PLUG), AMC Entertainment (AMC), HubSpot (HUBS), Peabody Energy (BTU), Fisker (FSR) and Tesla (TSLA).

Company Calendar

• Today: 7/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IINN
• CIK: 1837493
• Web: inspira-technologies.com
• Phone: 972-4623-0333
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $2.00
• High Stock Price Target: $2.00
• Low Stock Price Target: $2.00
• Potential Upside/Downside: +29.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 2.02
• Quick Ratio: 1.89

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.34 per share
• Price / Book: 4.53

Miscellaneous

• Outstanding Shares: 12,620,000
• Free Float: 8,910,000
• Market Cap: $19.43 million
• Optionable: Not Optionable
• Beta: 2.24